Cited by 119Probiotics and Fermented FoodsCholesterol and Lipid MetabolismGut microbiota and health

Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario

Choi, Sy-Bing, Lew, Lee-Ching, Yeo, Siok-Koon, Nair Parvathy, Seema, Liong, Min-Tze·2015·Critical Reviews in Biotechnology

Abstract

Probiotic microorganisms have been documented over the past two decades to play a role in cholesterol-lowering properties via various clinical trials. Several mechanisms have also been proposed and the ability of these microorganisms to deconjugate bile via production of bile salt hydrolase (BSH) has been widely associated with their cholesterol lowering potentials in prevention of hypercholesterolemia. Deconjugated bile salts are more hydrophobic than their conjugated counterparts, thus are less reabsorbed through the intestines resulting in higher excretion into the feces. Replacement of new bile salts from cholesterol as a precursor subsequently leads to decreased serum cholesterol levels. However, some controversies have risen attributed to the activities of deconjugated bile acids that repress the synthesis of bile acids from cholesterol. Deconjugated bile acids have higher binding affinity towards some orphan nuclear receptors namely the farsenoid X receptor (FXR), leading to a suppressed transcription of the enzyme cholesterol 7-alpha hydroxylase (7AH), which is responsible in bile acid synthesis from cholesterol. This notion was further corroborated by our current docking data, which indicated that deconjugated bile acids have higher propensities to bind with the FXR receptor as compared to conjugated bile acids. Bile acids-activated FXR also induces transcription of the IBABP gene, leading to enhanced recycling of bile acids from the intestine back to the liver, which subsequently reduces the need for new bile formation from cholesterol. Possible detrimental effects due to increased deconjugation of bile salts such as malabsorption of lipids, colon carcinogenesis, gallstones formation and altered gut microbial populations, which contribute to other varying gut diseases, were also included in this review. Our current findings and review substantiate the need to look beyond BSH deconjugation as a single factor/mechanism in strain selection for hypercholesterolemia, and/or as a sole mean to justify a cholesterol-lowering property of probiotic strains.

Integrity signals

Registry

Crossref · 10.3109/07388551.2014.889077

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Choi, S.-B., Lew, L.-C., Yeo, S.-K., Nair Parvathy, S., & Liong, M.-T.
Affiliations
  • Universiti Sains Malaysia (MY)
  • Taylor's University (MY)
Corresponding author
Liong, Min-Tze
Venue
Critical Reviews in Biotechnology
Published
2014-02-27
Volume
35
Issue
3
Pages
392-401
ISSN
  • 0738-8551 (ISSN-L)
  • 1549-7801
OpenAlex
W2024812562
Cited by
119
References
52
Citations by year
2026: 10 · 2025: 20 · 2024: 14 · 2023: 13 · 2022: 13 · 2021: 12 · 2020: 8 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 2 · 2015: 3 · 2014: 5
FWCI
0.62
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, bile salt hydrolase, cholesterol lowering, bile acid deconjugation, hypercholesterolemia, farnesoid X receptor, CYP7A1, molecular docking, fat malabsorption, gallstones, gut microbiota, probiotic strain selection
MeSH terms
Amidohydrolases, Animals, Cholesterol, Humans, Probiotics, Mice, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review